| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―19 |
Markers of inflammation and angiogenesis in patients with ischemic stroke after the new coronavirus infection |
Kh.V. Butaeva, O.N. Voskresenskaya, B.A. Abusueva, N.B. Zakharova |
| 2 |
[GO] |
2025―Aug―29 |
Sleep disorders after COVID-19 in patients with primary headaches |
E.A. Tveritin, D.A. Konovalova, D.V. Khamzin, M.L. Chigareva, E.A. Sizikova, E.A. Deriglazova, A.E. Ryazanova, D.V. Gilev, M.G. Poluektov, E.R. Lebedeva |
| 3 |
[GO] |
2025―Jun―27 |
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction |
V.I. Ershov, A.S. Dobrynin, A.A. Golubkina |
| 4 |
[GO] |
2025―Jun―03 |
Therapeutic potential of quercetin and its derivatives against COVID-19 |
A.B. Katasonov |
| 5 |
[GO] |
2025―Apr―08 |
Effect of the new coronavirus infection COVID-19 on the course and prognosis of tuberculous meningoencephalitis in HIV-infected patients |
A.A. Savin, E.B. Tsomaeva, A.V. Bugun, S.P. Sergeeva, M.R. Zyuzya, L.A. Savin, E.Yu. Romanova, O.A. Girusova |
| 6 |
[GO] |
2025―Mar―24 |
Coronavirus infection as a risk factor in occlusive-stenotic lesions of the brachiocephalic arteries |
A.L. Lushchik, E.A. Kalaeva, V.N. Kalaev, N.G. Zhukova, O.V. Bragina, I.A. Firsova |
| 7 |
[GO] |
2025―Jan―20 |
Clinical and epidemiological indicators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region |
M.V. Sutormin, E.P. Kakorina, I.V. Samorodskaya, S.V. Kotov |
| 8 |
[GO] |
2024―Aug―22 |
Cases of successful thrombus extraction in ischemic stroke associated with the new coronavirus infection COVID-19 |
L.T. Khasanova, Z.D. Kazakova, O.I. Patsap, A.K. Nikogosova, N.A. Shamalov |
| 9 |
[GO] |
2024―Aug―08 |
Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19 |
V.B. Popova, E.A. Antonova, P.M. Hlyabova, I.S. Rodyukova, D.N. Alpenidze, Yu.V. Drozdova, K.I. Shamaeva, S.M. Kryzhanovsky, A.S. Tarakanova, E.V. Yakubova, A.V. Ivaschenko, A.A. Ivaschenko |
| 10 |
[GO] |
2024―Aug―08 |
Neuprotection of post-acute COVID-19 cognitive impairment |
E.A. Melnik |
| 11 |
[GO] |
2024―Mar―26 |
The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study |
S.A. Sivertseva, K.S. Anfilofeva, A.V. Zotova, V.A. Kazantsev, A.Yu. Belkina, L.I. Volkova, M.E. Guseva, A.N. Boyko |
| 12 |
[GO] |
2024―Mar―11 |
Trends in the incidence of mental and behavioral disorders during the COVID-19 pandemic in Penza Oblast |
E.V. Petrova, N.I. Mikulyak, L.A. Sorokina, I.A. Sorokin |
| 13 |
[GO] |
2024―Jan―23 |
Attention deficit hyperactivity disorder in children and adolescents: lessons from the COVID-19 pandemic |
L.S. Chutko, V.V. Fateeva, S.Yu. Surushkina |
| 14 |
[GO] |
2023―Dec―26 |
Neurological complications after covid-19 vaccination |
K.M. Khalimova, N.S. Rashidova, J.J. Salimjonov |
| 15 |
[GO] |
2023―Dec―21 |
EEG correlates of suicidal intentions in depressive patients who survived and have not been ill with COVID-19 |
A.F. Iznak, E.V. Iznak, E.V. Damyanovich, I.V. Oleichik |
| 16 |
[GO] |
2023―Dec―21 |
Structure and dynamics of depressive disorders in patients with a new coronavirus infection |
N.N. Osipova, E.O. At’kova, D.D. Akimova, E.V. Dmitrieva, L.M. Bardenshtein |
| 17 |
[GO] |
2023―Nov―15 |
Changes in sleep patterns and the doom-scrolling (doom-surfing) phenomenon as modifiable risk factors for anxiety due to continuous stress of the COVID-19 pandemic |
T.S. Syunyakov, A.V. Zakharov, A.J. Gayduk, J.S. Ignatenko, N.Y. Kuvshinova, A.V. Pavlichenko, A.A. Spikina, I.A. Fedotov, A.A. Yashikhina, X. Gonda, A. Desousa, K.N. Fountoulakis, D.A. Smirnova |
| 18 |
[GO] |
2023―Aug―10 |
Relationship of patients with multiple sclerosis to vaccination against COVID-19 |
E.L. Turova |
| 19 |
[GO] |
2023―Jul―25 |
Prevalence and risk factors of delirium in COVID-19 |
Yu.G. Tikhonova, M.A. Kinkulkina, A.V. Volkov, V.A. Sedelkova, T.I. Avdeeva, T.A. Izyumina, M.A. Makarova, T.N. Maximova, M.Yu. Brovko, S.V. Moiseev, N.N. Ivanets |
| 20 |
[GO] |
2023―Jun―29 |
An analysis of suicidal behavior in adolescents before and during the COVID-19 pandemic: gender and age aspects |
N.B. Semenova, E.R. Slobodskaya, E.V. Rezun |
| 21 |
[GO] |
2023―Jun―29 |
Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection |
L.A. Belova, V.V. Mashin, D.R. Dolgova, A.A. Kuvayskaya, L.R. Kruglova, S.S. Sukhikh, T.D. Plaksina |
| 22 |
[GO] |
2023―Jun―14 |
An impact of the COVID-19 pandemia on the onset and course of mental disorders in elderly |
O.B. Yakovleva, T.P. Safarova, D.A. Tsvetaeva |
| 23 |
[GO] |
2023―May―04 |
Mental disorders associated with acute COVID-19: clinical picture, therapy approaches |
M.A. Samushiya, S.A. Chorbinskaya, E.A. Kolpakov, V.I. Shmyrev, S.M. Kryzhanovskiy, O.P. Baranovskaya, E.V. Trifonova, A.V. Devyatkin, N.A. Kydryavtseva, V.O. Maeva, E.V. Schepkina |
| 24 |
[GO] |
2023―May―04 |
Psychological, psychiatric and neurological aspects of COVID-19 |
D.F. Chritinin, V.K. Shamrey, I.V. Litvinenko, E.S. Kurasov, N.V. Tsygan, Yu.I. Vainshenker |
| 25 |
[GO] |
2023―Mar―23 |
Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke |
G.S. Rakhimbayeva, Sh.R. Gazieva, M.K. Ataniyazov, F.H. Muratov, D.S. Tolipov, U.D. Shodiev |
| 26 |
[GO] |
2023―Mar―22 |
Possibilities of optimizing therapy in COVID-19 survivors with focal epilepsy |
I.V. Ponomareva, S.B. Stepanova, S.A. Reneva, E.V. Sorokova, M.A. Vagina, O.A. Makodzeba, T.R. Galiullin |
| 27 |
[GO] |
2023―Mar―22 |
Impact of COVID-19 on some neurological and psychological features in epilepsy |
N.D. Sorokina, S.S. Pertsov, G.V. Selitsky, A.S. Zherdeva, A.V. Tsagashek |
| 28 |
[GO] |
2023―Mar―22 |
The impact of depression symptoms on postmorbid adaptation of patients who have undergone SARS-CoV-2 infection (assessment from the position of the multimorbidity model) |
A.N. Barkhatova, S.A. Sorokin, M.I. Bolgov, A.O. Smolnikova |
| 29 |
[GO] |
2023―Feb―27 |
Clinical and neurophysiological parameters in patients with epilepsy in the long-term period after COVID-19 |
G.V. Selitskiy, N.D. Sorokina, S.S. Pertsov, A.S. Zherdeva, A.V. Tsagashek |
| 30 |
[GO] |
2023―Feb―27 |
Current approaches in the treatment and rehabilitation of patients with neurological diseases after COVID-19. Resolution of the International Experts Forum |
O.S. Levin, V.V. Vashchilin, S. Pikija, D.R. Khasanova, S.T. Turuspekova, A.N. Bogolepova, A.A. Shmonin, M.N. Maltceva, I.A. Vozniuk, S.N. Yanishevskiy, D.K. Huseynov, Y.V. Karakulova, F.Kh. Obidov |
| 31 |
[GO] |
2023―Feb―27 |
The alleged mechanisms of olfactory disorders in the new coronavirus infection |
N.Y. Lashch, A.R. Yunyaev, E.D. Evsyukova |
| 32 |
[GO] |
2023―Jan―31 |
Behavioral (non-chemical) addictions and COVID-19 |
A.Y. Egorov |
| 33 |
[GO] |
2022―Dec―30 |
Clinical and pathophysiological features of stroke in patients with COVID-19 |
A.A. Rubakova, J.I. Lebedeva, E.F. Turovina, Sun Cher I, L.T. Khasanova, A.Ju. Suvorov, Z.D. Kazakova |
| 34 |
[GO] |
2022―Dec―30 |
Ethiopathogenetic features and course of ischemic stroke associated with COVID-19 |
L.B. Novikova, R.F. Latypova |
| 35 |
[GO] |
2022―Dec―20 |
Personality traits as risk factors for the development of cognitive impairment and affective symptoms in patients with COVID-19 |
A.A. Zemlyanaya, V.V. Kalinin, I.V. Damulin, E.A. Fedorenko, M.A. Syrtsev |
| 36 |
[GO] |
2022―Dec―20 |
Gustatory disorders in COVID-19 |
N.G. Zhukova, N.A. Kicherov, M.E. Semykin |
| 37 |
[GO] |
2022―Dec―20 |
The state of cognitive functions in patients with coronavirus infection in the acute period of the disease (outbreaks in 2020-2022) |
S.S. Kabysh, S.V. Prokopenko, A.D. Karpenkova, E.G. Shanina |
| 38 |
[GO] |
2022―Nov―28 |
Cognitive consequences of COVID-19 |
O.A. Kicherova, L.I. Reikhert, M.A. Akhmetyanov, M.V. Deeva, D.V. Makarova |
| 39 |
[GO] |
2022―Nov―22 |
An analysis of clinical and laboratory characteristics of patients with ischemic stroke and COVID-19 |
A.R. Rakhmatullin, M.A. Kutlubaev |
| 40 |
[GO] |
2022―Oct―24 |
A rare case of multifocal leukoencephalopathy and cerebral stroke after SARS-CoV-2 infection |
O.V. Vorobeva |
| 41 |
[GO] |
2022―Sep―28 |
Guillain-Barre syndrome associated with COVID-19 |
A.A. Bogdanova, E.S. Kravtsunova, A.I. Raevskaia, An.S. Karpov, R.N. Gadaborshev, A.I. Dzutsev, I.A. Vyshlova, S.M. Karpov |
| 42 |
[GO] |
2022―Sep―28 |
Cerebral venous thrombosis associated with COVID-19 |
D.R. Safina, E.I. Gismatullina, R.G. Esin |
| 43 |
[GO] |
2022―Sep―28 |
Post COVID-19 disorders: is the epidemic of parkinsonism threatening the world? |
I.V. Damulin, A.A. Strutzenko |
| 44 |
[GO] |
2022―Sep―28 |
COVID-19-associated damage of the peripheral nervous system |
S.G. Burd, A.V. Lebedeva, G.G. Avakyan, Yu.V. Rubleva, N.V. Pantina, A.V. Yurchenko, I.I. Kovaleva |
| 45 |
[GO] |
2022―Aug―29 |
Predictors of unfavorable outcomes of ischemic stroke associated with COVID-19 |
L.B. Novikova, R.F. Latypova |
| 46 |
[GO] |
2022―Aug―29 |
Features of psychoemotional status in patients with chronic thromboembolic pulmonary hypertension after cardiac surgery during the COVID-19 pandemic |
A.S. Klinkova, O.V. Kamenskaya, I.Y. Loginova, S.S. Porotnikova, V.N. Lomivorotov, A.M. Chernyavskiy, V.V. Lomivorotov |
| 47 |
[GO] |
2022―Aug―29 |
The case of the development of ischemic stroke and cerebral edema after SARS-COV-2 infection in a patient with discirculatory encephalopathy and concomitant schizophrenia |
O.V. Vorobeva, L.P. Romanova |
| 48 |
[GO] |
2022―Jul―07 |
Clinical and immunological correlates in endogenous psychoses developed after COVID-19 |
S.A. Zozulya, S.V. Sizov, I.V. Oleichik, T.P. Klyushnik |
| 49 |
[GO] |
2022―Jul―07 |
Depression - the pandemic of the XXI century |
|
| 50 |
[GO] |
2022―Jun―27 |
Sleep disorders in nurses working during the COVID-19 pandemic |
A.D. Ibatov, M.I. Kubareva, N.V. Afanasyeva, A.M. Narbut, L.A. Zakharova, J.V. Nagibina, M.V. Eliseeva, I.V. Kolesnikova |
| 51 |
[GO] |
2022―Jun―27 |
Stress, anxiety, depression and burnout in healthcare workers during the first two outbreaks of COVID-19 in Russia |
E.S. Mosolova, D.N. Sosin |
| 52 |
[GO] |
2022―Jun―27 |
Characteristics of student response to pandemic in cross-cultural context |
B.D. Tsygankov, A.A. Ovchinnikov, A.N. Sultanova, U.H. Gadzhieva, M.Yu. Narov, L.D. Rakhmazova, K.B. Ateev, E.V. Tagiltseva |
| 53 |
[GO] |
2022―May―25 |
Correction of psychoemotional disorders and short-term prognosis in patients with COVID-19 |
V.N. Shishkova, K.E. Imamgayazova, L.A. Kapustina |
| 54 |
[GO] |
2022―Apr―28 |
Neurological aspects of the consequences of COVID-19 in children |
S.A. Nemkova |
| 55 |
[GO] |
2022―Apr―12 |
The effect of antiplatelet therapy on the course of COVID-19 |
L.A. Edilgireeva, T.A. Sadulaeva, V.V. Zakharov, N.V. Vakhnina |
| 56 |
[GO] |
2022―Mar―10 |
An impact of COVID-19 on the course of epilepsy |
G.V. Odincova, O.V. Nezdorovin, V.G. Nezdorovina |
| 57 |
[GO] |
2022―Feb―17 |
Lichen planus, COVID-19 and depression: psychosomatic correlations |
I.Yu. Dorozhenok, E.S. Snarskaya, M.V. Mikhailova |
| 58 |
[GO] |
2022―Jan―19 |
COVID-19 and cerebral stroke |
V.G. Pomnikov, I.V. Sakovskiy, T.A. Yashchikhina, O.V. Dudkina |
| 59 |
[GO] |
2022―Jan―19 |
COVID-19 related stroke |
I.A. Shchukin, M.S. Fidler, I.A. Koltsov, A.Yu. Suvorov |
| 60 |
[GO] |
2022―Jan―18 |
Sleep Disorders in Patients After COVID-19 |
M.A. Ahmet’yanov, L.I. Reikhert, O.A. Kicherova, D.M. Veeva, D.V. Makarova |
| 61 |
[GO] |
2022―Jan―18 |
The effectiveness of cytoflavin in complex therapy of patients with the coronavirus infection COVID-19 |
E.V. Ekusheva, V.B. Voitenkov, O.A. Rizakhanova |
| 62 |
[GO] |
2022―Jan―18 |
Some psychiatric and neurological aspects of the asymptomatic and mild course of COVID-19 |
D.F. Chritinin, V.K. Shamrey, E.S. Kurasov, I.V. Litvinenko, N.V. Tsygan, S.Yu. Golokhvastov, A.V. Ryabtsev |
| 63 |
[GO] |
2021―Dec―30 |
The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study) |
I.N. Samartsev, S.A. Zhivolupov, J.S. Butakova, M.S. Parshin |
| 64 |
[GO] |
2021―Dec―21 |
Cerebral circulation disorders in COVID-19 |
V.E. Kitaeva, A.S. Kotov, M.S. Bunak |
| 65 |
[GO] |
2021―Dec―07 |
Carotid endarterectomy in patients with internal carotid artery thrombosis in the acutest period of ischemic stroke with COVID-19 |
A.N. Kazantsev, K.P. Chernykh, S.V. Artyukhov, G.Sh. Bagdavadze, M.O. Dzhanelidze, R.Yu. Lider, A.D. Abdullaev, N.E. Zarkua, E.Yu. Kalinin, A.E. Chikin, T.E. Zaitseva, Yu.P. Linets |
| 66 |
[GO] |
2021―Dec―06 |
Neurological complications of COVID-19 in elderly people |
A.J. Nikitina, A.Sh. Chimagomedova, O.S. Levin |
| 67 |
[GO] |
2021―Dec―06 |
Chronic fatigue syndrome against the background of the COVID-19 pandemic |
A.J. Nikitina, O.S. Levin |
| 68 |
[GO] |
2021―Oct―25 |
Guillain-Barre syndrome with cranial nerve damage as complication of COVID-19 |
A.K. Shakaryan, S.K. Pylaeva, N.E. Perekopskaya, R.F. Sayfullin, A.V. Belyakova |
| 69 |
[GO] |
2021―Oct―25 |
Risk and course of COVID-19 in patients with Parkinson’s disease |
Z.A. Zalyalova, D.M. Khasanova |
| 70 |
[GO] |
2021―Sep―23 |
COVID-19-associated stroke |
S.V. Zabolotnaya, A.N. Bogolepova, R.T. Tairova |
| 71 |
[GO] |
2021―Sep―06 |
Correction of mitochondrial dysfunction in the complex rehabilitation of COVID-19 |
A.E. Tereshin, V.V. Kiryanova, D.A. Reshetnik |
| 72 |
[GO] |
2021―Sep―06 |
About the causes and therapy of depressive disorders in COVID-19 |
E.Y. Abritalin |
| 73 |
[GO] |
2021―Sep―06 |
Clinical manifestations of COVID-19 in children |
D.R. Shagieva, A.R. Rakhmatullin, M.A. Kutlubaev, V.F. Tunik, R.V. Magzhanov |
| 74 |
[GO] |
2021―Aug―30 |
Dynamics of psychopathological symptoms during the COVID-19 pandemic in Russia |
T.I. Medvedeva, S.N. Enikolopov, O.M. Boyko, O.Yu. Vorontsova, O.Yu. Kazmina |
| 75 |
[GO] |
2021―Aug―18 |
COVID-19 and stress-related disorders |
O.V. Kotova, V.E. Medvedev, E.S. Akarachkova, A.A. Belyaev |
| 76 |
[GO] |
2021―Aug―13 |
Monoclonal antibody therapies for rapidly progressive and highly active multiple sclerosis in the era of the COVID-19 pandemic |
D.D. Eliseeva, A.V. Vasiliev, A.A. Abramova, I.A. Kochergin, M.N. Zakharova |
| 77 |
[GO] |
2021―Jul―20 |
Current issues of treatment and rehabilitation of patients with neurological disorders and the consequences of COVID-19. Resolution of Advisory Board |
G.E. Ivanova, A.N. Bogolepova, O.S. Levin, N.A. Shamalov, D.R. Khasanova, S.N. Yanishevsky, V.V. Zakharov, S.E. Khatkova, L.V. Stakhovskya |
| 78 |
[GO] |
2021―Jun―29 |
Polyneuropathies during COVID-19 epidemics |
M.L. Chukhlovina |
| 79 |
[GO] |
2021―Jun―03 |
Novel coronavirus disease (COVID-19) and obstructive sleep apnea: age aspects of comorbidity |
O.N. Berdina, I.M. Madaeva, L.V. Rychkova |
| 80 |
[GO] |
2021―Jun―03 |
COVID-19 effect on mental health and sleep disorders |
M.A. Samushiya, S.M. Kryzhanovsky, A.A. Ragimova, T.Z. Berishvili, S.A. Chorbinskaya, E.I. Ivannikova |
| 81 |
[GO] |
2021―Jun―03 |
Psychological factors of sleep and daytime complaints during the COVID-19 Lockdown: the role of anxiety, well-being, autonomy, and coping |
E.I. Rasskazova |
| 82 |
[GO] |
2021―Jun―03 |
Infections, pandemics and sleep disorders |
O.V. Kolokolov, E.A. Salina, V.V. Yudina, A.A. Shuldyakov, A.E. Runnova |
| 83 |
[GO] |
2021―May―26 |
Amantadine in the treatment of Parkinson’s disease. New opportunities in the context of COVID-19 |
E.A. Katunina |
| 84 |
[GO] |
2021―Apr―28 |
Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19 |
V.V. Kovalchuk, I.I. Ershova, N.V. Molodovskaya |
| 85 |
[GO] |
2021―Apr―09 |
Mental health assessment of medical workers during the COVID-19 pandemic in Russia: results of an online survey |
E.V. Bachilo, D.E. Novikov, A.A. Efremov |
| 86 |
[GO] |
2021―Feb―13 |
Effects of COVID-19 on the central nervous system |
O.V. Kurushina, A.E. Barulin |
| 87 |
[GO] |
2021―Jan―18 |
Acute cerebrovascular accidents associated with SARS-CoV-2 coronavirus infection (COVID-19) |
M.V. Putilina, V.I. Vechorko, D.V. Grishin, L.V. Sidelnikova |
| 88 |
[GO] |
2020―Dec―19 |
Direct and indirect neurological manifestations of COVID-19 |
O.A. Gromova, I.Yu. Torshin, V.A. Semenov, M.V. Putilina, A.G. Chuchalin |
| 89 |
[GO] |
2020―Nov―27 |
Mental health of population during the COVID-19 pandemic |
E.V. Bachilo |
| 90 |
[GO] |
2020―Nov―27 |
Epilepsy and COVID-19: patient management and optimization of antiepileptic therapy during pandemic |
F.K. Rider, A.V. Lebedeva, V.R. Mkrtchyan, A.B. Guekht |
| 91 |
[GO] |
2020―Oct―21 |
Clinical and pathogenetic aspects of nervous system impairments in COVID-19 |
M.A. Kutlubaev |
| 92 |
[GO] |
2020―Oct―21 |
Pandemic COVID-19 and mental disorders international experience and therapeutic approaches |
A.V. Vasileva |
| 93 |
[GO] |
2020―Oct―21 |
Features of neurological manifestations of the COVID-19 in children and adults |
A.A. Kholin, N.N. Zavadenko, Yu.E. Nesterovskiy, E.A. Kholina, A.N. Zavadenko, G.Sh. Khondkaryan |
| 94 |
[GO] |
2020―Oct―20 |
Sleep in an era of coronavirus |
M.G. Poluektov |
| 95 |
[GO] |
2020―Oct―05 |
SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies |
M.V. Putilina, D.V. Grishin |
| 96 |
[GO] |
2020―Oct―05 |
Current issues in the rehabilitation of stroke patients against the background of a new coronavirus infection (COVID-19). Resolution of the Council of Experts |
G.E. Ivanova, E.V. Melnikova, O.S. Levin, S.E. Khatkova, D.R. Khasanova, S.N. Yanishevsky, V.D. Daminov, E.E. Vasenina, M.V. Gurkina |
| 97 |
[GO] |
2020―Jul―17 |
Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care |
E.I. Gusev, M.Yu. Martynov, A.N. Boyko, I.A. Voznyuk, N.Yu. Latsh, S.A. Sivertseva, N.N. Spirin, N.A. Shamalov |
| 98 |
[GO] |
2020―Jul―04 |
Problems of mental health in the situation of COVID-19 pandemic |
S.N. Mosolov |
| 99 |
[GO] |
2020―Jul―04 |
Pandemic and mental adjustment disorders. Therapy options |
A.V. Vasileva |
